关注
Mickael Dang, PhD
Mickael Dang, PhD
Postdoctoral Fellow, University of Toronto
在 mail.utoronto.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Stable oxime-crosslinked hyaluronan-based hydrogel as a biomimetic vitreous substitute
AEG Baker, H Cui, BG Ballios, S Ing, P Yan, J Wolfer, T Wright, M Dang, ...
Biomaterials 271, 120750, 2021
472021
Affibody-mediated controlled release of fibroblast growth factor 2
C Bostock, CJ Teal, M Dang, AW Golinski, BJ Hackel, MS Shoichet
Journal of Controlled Release 350, 815-828, 2022
102022
Synthesis of an Enzyme-Mediated Reversible Cross-linked Hydrogel for Cell Culture
KA Smith, M Dang, AEG Baker, T Fuehrmann, A Fokina, MS Shoichet
Biomacromolecules, 2021
82021
Long‐Acting Ocular Injectables: Are We Looking In The Right Direction?
M Dang, MS Shoichet
Advanced Science 11 (8), 2306463, 2024
42024
Colloid‐Forming Prodrug‐Hydrogel Composite Prolongs Lower Intraocular Pressure in Rodent Eyes after Subconjunctival Injection
M Dang, KV Slaughter, H Cui, C Jiang, L Zhou, DJ Matthew, JM Sivak, ...
Advanced Materials, 2419306, 2025
2025
A Mechanically Resilient Soft Hydrogel Improves Drug Delivery for Treating Post-Traumatic Osteoarthritis in Physically Active Joints
N Joshi, J Yan, M Dang, K Slaughter, Y Wang, D Wu, T Ung, V Pandya, ...
bioRxiv, 2024.05. 16.594611, 2024
2024
Injectable and Biodegradable Vitreous Substitute
A Forman, H Cui, AEG Baker, M Dang, JM Labriola, VA Wallace, ...
Investigative Ophthalmology & Visual Science 64 (8), 5289-5289, 2023
2023
Enzyme-degradable, Reversible Crosslinked Hydrogel For Cell Culture
M Dang, KA Smith, AE Baker, A Fokina, MS Shoichet
TISSUE ENGINEERING PART A 28, 353-354, 2022
2022
Injectable And Biodegradable Vitreous Substitute
AE Baker, A Forman, H Cui, M Dang, R Devenyi, MS Shoichet
TISSUE ENGINEERING PART A 28, 66-67, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–9